{"id":3671,"company":{"country":"US","currency":"USD","exchange":"NEW YORK STOCK EXCHANGE, INC.","ipo":"1970-07-09","marketCap":771282.5,"name":"Eli Lilly and Co","phone":"13172762000","outstanding":950.4099731445312,"symbol":"LLY","website":"https://www.lilly.com/","industry":"Pharmaceuticals"},"price":808.0575,"year":2024,"month":5,"day":30,"weekday":"Thursday","title":"Historical Volatility of Eli Lilly and Co Stock and its Impact on Investor Behavior","date":"2024-05-30","url":"/posts/2024/05/30/LLY","content":[{"section":"Introduction","text":"Eli Lilly and Co is a pharmaceutical company that has been listed on the stock market for many years. As with any publicly traded stock, the price of Eli Lilly and Co stock is subject to fluctuations in the market. Historical volatility is a statistical measure that quantifies these fluctuations."},{"section":"Historical Volatility","text":"To calculate historical volatility, the daily returns of Eli Lilly and Co stock over a specified time period are analyzed. The standard deviation of these returns provides a measure of the stock's volatility. A higher historical volatility indicates greater price fluctuations, while lower historical volatility suggests more stable price movements."},{"section":"Impact on Investor Behavior","text":"The historical volatility of a stock can significantly impact investor behavior. High volatility may deter risk-averse investors, as they may fear substantial losses during periods of market turbulence. On the other hand, some investors seek out volatile stocks, as they present opportunities for large gains. Thus, the historical volatility of Eli Lilly and Co stock can influence the composition of its investor base."},{"section":"Risk Management Strategies","text":"Investors employ various risk management strategies to mitigate potential losses arising from stock price volatility. One approach is diversification, which involves spreading investments across different industries, asset classes, and regions. By diversifying their holdings, investors can reduce exposure to any single stock, such as Eli Lilly and Co, and minimize the impact of its volatility on their overall portfolio."},{"section":"Another risk management strategy is setting stop-loss orders. These orders automatically sell a stock if its price falls below a specified level. By using stop-loss orders, investors can limit their losses if Eli Lilly and Co stock experiences a significant decline in value.","text":""},{"section":"Additionally, some investors may choose to hedge their positions using options. Buying put options, for example, allows investors to protect against a decline in Eli Lilly and Co stock price, thereby mitigating potential losses.","text":""},{"section":"Conclusion","text":"The historical volatility of Eli Lilly and Co stock plays a crucial role in shaping investor behavior. Investors weighing the potential gains against the risks associated with the stock's price fluctuations. Employing risk management strategies such as diversification, stop-loss orders, and options hedging can help investors manage their exposure to the volatility of Eli Lilly and Co and other stocks in their portfolio."}],"tags":["LongSignals","Long","Pharmaceuticals"],"news":[{"category":"company","date":1717016521,"headline":"FDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain Mutations","id":127968120,"image":"https://media.zenfs.com/en/Benzinga/ea3303b2cc17ec94f347812d09380783","symbol":"LLY","publisher":"Yahoo","summary":"Wednesday, the FDA granted accelerated approval to Eli Lilly And Co’s (NYSE:LLY) selpercatinib (Retevmo) for pediatric patients two years of age and older with the following: Advanced or metastatic medullary thyroid cancer (MTC) with a RET mutation, who require systemic therapy. Advanced or metastatic thyroid cancer with a RET gene fusion, who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate). Locally advanced or metastatic solid tumors wit","url":"https://finance.yahoo.com/news/fda-conditionally-approves-eli-lillys-210201141.html"},{"category":"company","date":1717004721,"headline":"Eli Lilly's Retevmo Gets FDA Accelerated Approval for Kids With RET-altered Thyroid Cancer, Solid Tumors","id":127968121,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly's Retevmo Gets FDA Accelerated Approval for Kids With RET-altered Thyroid Cancer, Solid Tumors","url":"https://finance.yahoo.com/news/eli-lilly-apos-retevmo-gets-174521779.html"},{"category":"company","date":1716994454,"headline":"Lilly, Amazon Pump Billions Into Indiana’s Industrial Resurgence","id":127968123,"image":"https://s.yimg.com/ny/api/res/1.2/KgNouCtgXQvxsexcMwTcYw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD01Njk-/https://media.zenfs.com/en/bloomberg_markets_842/3c8aff6be7fae029ca01b380fb2da04d","symbol":"LLY","publisher":"Yahoo","summary":"(Bloomberg) -- An industrial renaissance is fueling record capital inflows into Indiana, putting the Midwestern state on pace to surpass last year’s almost $29 billion in investments.Most Read from BloombergWorld’s Largest Nuclear Plant Sits Idle While Energy Needs Soar‘Not Gonna Be Pretty:’ Covid-Era Homebuyers Face Huge Rate JumpWarning Signals Are Flashing for Homeowners in Texas and FloridaNew BYD Hybrid Can Drive Non-Stop for More Than 2,000 KilometersWall Street Returns to T+1 Stock Tradin","url":"https://finance.yahoo.com/news/lilly-amazon-pump-billions-indiana-145414145.html"},{"category":"company","date":1716982740,"headline":"Lilly's Retevmo gains approval for children as young as two with thyroid cancer","id":127963834,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3517145387"},{"category":"company","date":1716981743,"headline":"Eli Lilly: donates $6.5 million to UNICEF fund","id":127955615,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"Eli Lilly has announced a $6.5 million donation to the U.S. Fund for UNICEF to improve the health of children and young people at risk of non-communicable diseases in India. This donation brings...","url":"https://finnhub.io/api/news?id=a5873a1d105b949c1f8ad23ba0fe1fa65dc6d334a28760d14ee1e5abde9e0e1e"},{"category":"company","date":1716981300,"headline":"Ro provides supply tracking feature for Lilly, Novo Nordisk weight loss drugs","id":127962464,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3517114622"},{"category":"company","date":1716981300,"headline":"FDA grants Lilly's Retevmo accelerated approval for thyroid cancer","id":127963835,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3517116427"},{"category":"company","date":1716978600,"headline":"Harding Loevner International Equity ADR Composite Q1 2024 Report","id":127955420,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1335295270/image_1335295270.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"The International Equity ADR composite rose 2.26% in the quarter gross of fees, trailing the 4.81% gain for the MSCI ACWI ex US Index.","url":"https://seekingalpha.com/article/4696221-harding-loevner-international-equity-adr-composite-q1-2024-report"},{"category":"company","date":1716977700,"headline":"Could Eli Lilly Be the Next to Join the Trillion-Dollar Club?","id":127968124,"image":"https://g.foolcdn.com/editorial/images/778758/scientists-high-five-smile.jpg","symbol":"LLY","publisher":"Yahoo","summary":"Today, Eli Lilly's market value tops $700 billion.","url":"https://www.fool.com/investing/2024/05/29/could-eli-lilly-be-the-next-to-join-the-trillion-d/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1716976800,"headline":"Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases","id":127968126,"image":"https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee","symbol":"LLY","publisher":"Yahoo","summary":"During the World Health Assembly today, Eli Lilly and Company (NYSE: LLY) announced it will donate $6.5 million to the United States Fund for UNICEF to expand UNICEF's work to improve the health outcomes of millions of children and youth at risk of noncommunicable diseases (NCDs) living in resource-limited settings in India. This will bring the company's total commitment since 2022 to more than $20 million.","url":"https://finance.yahoo.com/news/lilly-unicef-expand-support-help-100000974.html"},{"category":"company","date":1716974700,"headline":"Harding Loevner International Equity Composite Q1 2024 Report","id":127955105,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1713124895/image_1713124895.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Harding Loevner's International Equity composite rose 1.74% in Q1'24 (gross) trailing the 4.81% gain for the MSCI ACWI ex US Index. Click here to read more.","url":"https://seekingalpha.com/article/4696214-harding-loevner-international-equity-composite-q1-2024-report"},{"category":"company","date":1716973500,"headline":"Harding Loevner Global Developed Markets Equity Composite Q1 2024 Report","id":127954931,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1302259920/image_1302259920.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"The Global Developed Markets Equity composite rose 7.4% gross of fees in the first quarter, trailing the 9.0% gain in the MSCI World Index.","url":"https://seekingalpha.com/article/4696207-harding-loevner-global-developed-markets-equity-composite-q1-2024-report"},{"category":"company","date":1716968880,"headline":"Jim Cramer Recommends Buying Apple, Finds This Tech Stock 'Very Interesting'","id":127956194,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3516864376"},{"category":"company","date":1716967800,"headline":"Harding Loevner Global Equity ADR Composite Q1 2024 Report","id":127953650,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1335295270/image_1335295270.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"The Global Equity ADR composite rose 7.4% gross of fees in the first quarter, trailing the 8.3% gain in the MSCI All Country World Index.","url":"https://seekingalpha.com/article/4696183-harding-loevner-global-equity-adr-composite-q1-2024-report"},{"category":"company","date":1716960720,"headline":"If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names","id":127958079,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3516727708"},{"category":"company","date":1716960000,"headline":"Harding Loevner Global Equity Composite Q1 2024 Report","id":127951749,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1765527692/image_1765527692.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Harding Loevner's Global Equity composite rose 6.9% (gross) in Q1'24 trailing the 8.3% gain in the MSCI All Country World Index. Click here for the full report.","url":"https://seekingalpha.com/article/4696161-harding-loevner-global-equity-composite-q1-2024-report"},{"category":"company","date":1716958680,"headline":"Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker","id":127961432,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3517587603"},{"category":"company","date":1716957540,"headline":"Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply","id":127962476,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3516682398"},{"category":"company","date":1716945540,"headline":"Stocks with momentum and at least 5% EPS revisions since end of March - Wolfe Research","id":127958310,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3517276792"},{"category":"company","date":1716931167,"headline":"Tracking Chase Coleman's Tiger Global Portfolio - Q1 2024 Update","id":127944396,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1126216811/image_1126216811.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Chase Coleman's Tiger Global Management 13F portfolio value grew to $18.3B, with top holdings in Meta Platforms, Microsoft, Alphabet and Apollo Global. See more.","url":"https://seekingalpha.com/article/4696110-tracking-chase-colemans-tiger-global-portfolio-q1-2024-update"},{"category":"company","date":1716918319,"headline":"Altimmune: A Potential Minor Player In The Massive GLP-1 Space","id":127939484,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2055844146/image_2055844146.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Altimmune, Inc. is a biotech company exploring the potential of pemvidutide, a promising GLP-1 agonist. Click here for my ALT stock update and look ahead.","url":"https://seekingalpha.com/article/4696091-altimmune-a-potential-minor-player-in-the-massive-glp-1-space"},{"category":"company","date":1716906990,"headline":"CHW: Very Impressive Recent Performance Could Result In Distribution Increase","id":127935443,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/168635061/image_168635061.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Calamos Global Dynamic Income Fund offers high income, geographic diversification, and strong performance for equity exposure. Click here for my CHW update.","url":"https://seekingalpha.com/article/4696060-chw-very-impressive-recent-performance-could-result-in-distribution-increase"},{"category":"company","date":1716904800,"headline":"Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference","id":127935421,"image":"https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly and Company (NYSE: LLY) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024. Patrik Jonsson, executive vice president, president of Lilly Diabetes and Obesity, and president of Lilly USA, will participate in a fireside chat at 4 p.m. Eastern time.","url":"https://finance.yahoo.com/news/lilly-participate-goldman-sachs-45th-140000835.html"},{"category":"company","date":1716901217,"headline":"Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It","id":127935422,"image":"https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee","symbol":"LLY","publisher":"Yahoo","summary":"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.","url":"https://finance.yahoo.com/news/eli-lilly-company-lly-trending-130017146.html"},{"category":"company","date":1716900120,"headline":"10 Health Care Stocks With Whale Alerts In Today's Session","id":127935104,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3515530572"},{"category":"company","date":1716899760,"headline":"Nvidia's Meteoric Rise: How Does It Compare To Other Market Rallies?","id":127936761,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3515523640"},{"category":"company","date":1716892563,"headline":"Dow Jones Futures Fall, But Nvidia Leads Techs Higher; 7 Stocks Near Buy Points","id":127930801,"image":"https://media.zenfs.com/en/ibd.com/f10524724103d3259783022b8cfa1bdc","symbol":"LLY","publisher":"Yahoo","summary":"The market rally had a mixed week as breadth narrowed. Microsoft and Merck led stocks near buy points. Here's what to do.","url":"https://finance.yahoo.com/m/048fae1e-3098-3f44-a989-47f3e5b60f32/dow-jones-futures-fall%2C-but.html"},{"category":"company","date":1716892320,"headline":"OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 \u0026 Weight Loss ETF","id":127936762,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3515367072"},{"category":"company","date":1716891780,"headline":"Bank of America’s ‘triple momentum’ screeners find stocks including Nvidia, JPMorgan","id":127936763,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3515355458"},{"category":"company","date":1716890646,"headline":"Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows","id":127931456,"image":"https://media.zenfs.com/en/reuters-finance.com/7f1bdb8cdf34983a9fa2dd1ec01f46d8","symbol":"LLY","publisher":"Yahoo","summary":"As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible  wider usage and a growing number of would-be rivals are leading some experts to raise annual global sales forecasts for the treatments to about $150 billion by the early 2030s.  \"It is very unusual to have a medicine that is capturing the imagination of millions of people,\" said Michael Kleinrock, senior research director at healthcare analytics firm IQVIA Institute for Data Science.  Most insurers do not cover the new therapies with low co-payments, but an unprecedented percentage of people are paying themselves or with coupons from drug manufacturers, he said.","url":"https://finance.yahoo.com/news/analysis-weight-loss-drug-forecasts-100406526.html"},{"category":"company","date":1716889800,"headline":"Bank of America’s ‘triple momentum’ screeners finds stocks including Nvidia, J.P.Morgan","id":127936765,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3515315477"},{"category":"company","date":1716885540,"headline":"Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?","id":127931786,"image":"https://g.foolcdn.com/editorial/images/778632/individual-investor-devices-getty.jpg","symbol":"LLY","publisher":"Yahoo","summary":"Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.","url":"https://www.fool.com/investing/2024/05/28/eli-lilly-stock-could-soar-24-according-to-a-wall/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1716885000,"headline":"Novo Nordisk: The Market Is Right, Don't Fight Against It","id":127932043,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1665778558/image_1665778558.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Discover why Novo Nordisk stock has outperformed the market and learn about its growth potential and potential challenges from competitors.","url":"https://seekingalpha.com/article/4695908-novo-nordisk-stock-market-is-right-dont-fight-against-it-maintain-hold"},{"category":"company","date":1716879120,"headline":"The Dividend Acceleration Squad: 3 Stocks With Rapidly Rising Yields","id":127936768,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3515119993"},{"category":"company","date":1716871320,"headline":"Analysts Conflicted on These Healthcare Names: Eli Lilly \u0026 Co (LLY) and Veeva Systems (VEEV)","id":127936770,"image":"","symbol":"LLY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3515015561"},{"category":"company","date":1716860283,"headline":"Dow Jones Futures Rise After  Holiday Weekend; 7 Stocks Near Buy Points","id":127925746,"image":"https://media.zenfs.com/en/ibd.com/f10524724103d3259783022b8cfa1bdc","symbol":"LLY","publisher":"Yahoo","summary":"The market rally had a mixed week as breadth narrowed. Microsoft and Merck led stocks near buy points. Here's what to do.","url":"https://finance.yahoo.com/m/048fae1e-3098-3f44-a989-47f3e5b60f32/dow-jones-futures-rise-after-.html"},{"category":"company","date":1716860580,"headline":"'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches","id":127936771,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3514894710"},{"category":"company","date":1716830043,"headline":"Dow Jones Futures Rise With U.S. Markets Shut; 7 Stocks Near Buy Points","id":127921279,"image":"https://media.zenfs.com/en/ibd.com/f10524724103d3259783022b8cfa1bdc","symbol":"LLY","publisher":"Yahoo","summary":"The market rally had a mixed week as breadth narrowed. Microsoft and Merck led stocks near buy points. Here's what to do.","url":"https://finance.yahoo.com/m/048fae1e-3098-3f44-a989-47f3e5b60f32/dow-jones-futures-rise-with.html"},{"category":"company","date":1716814140,"headline":"Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows","id":127920807,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3513906533"},{"category":"company","date":1716811320,"headline":"Eli Lilly (LLY) to Ramp Up Indiana Site for Mounjaro, Zepbound","id":127921746,"image":"https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6","symbol":"LLY","publisher":"Yahoo","summary":"Since 2020, Eli Lilly (LLY) has committed more than $18 billion to building new manufacturing sites as well as updating existing manufacturing facilities.","url":"https://finance.yahoo.com/news/eli-lilly-lly-ramp-indiana-120200224.html"},{"category":"company","date":1716797137,"headline":"Lilly doubles investment in Indiana site to enhance API manufacturing","id":127921747,"image":"https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/05/Lilly_LP1_04.jpg","symbol":"LLY","publisher":"Yahoo","summary":"The company is expanding its Indiana facility to increase API capacity for diabetes and obesity treatments.","url":"https://www.pharmaceutical-technology.com/news/lilly-investment-api-manufacturing/"},{"category":"company","date":1716793327,"headline":"Altimmune: Pemvidutide 15.6% Mean Weight Loss Could Bring Positive Returns","id":127919142,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1408626229/image_1408626229.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Altimmune is developing Pemvidutide, a drug that shows promising results in fat and weight loss.Â See why Pemvidutide's potential makes ALT stock a buy.","url":"https://seekingalpha.com/article/4695818-altimmune-pemvidutide-15-6-percent-mean-weight-loss-could-bring-positive-returns"},{"category":"company","date":1716790980,"headline":"Chinese Scientists Achieve World's First Diabetes Cure Using Cell Therapy: Report","id":127925106,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3514102522"},{"category":"company","date":1716784268,"headline":"Major manufacturing investment to support API production for tirzepatide","id":127918482,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"A new $5.3 billion investment for Eli Lilly and Company's manufacturing site in Lebanon, Indiana, US, increases the firm's total investment there from $3.7 billion to $9 billion. This expansion will...","url":"https://finnhub.io/api/news?id=5203c6b0323b9e435487215257c06ac8c56eedd59cf6fdb65fc17428eee3afd0"},{"category":"company","date":1716775080,"headline":"The Penny Stock Prophecy: 3 Overlooked Stocks Primed to Pop","id":127922000,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3514406488"},{"category":"company","date":1716736779,"headline":"Eli Lilly: Addressing Supply Challenges Should Accelerate Growth","id":127914910,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/521503314/image_521503314.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Eli Lilly's shares soar to new highs as it boosts revenue and EPS guidance. Analyzing its competitive position in the obesity market and promising pipeline.","url":"https://seekingalpha.com/article/4695745-eli-lilly-stock-lly-addressing-supply-challenges-should-accelerate-growth"},{"category":"company","date":1716732900,"headline":"Got $500? 3 Pharma Stocks to Buy and Hold Forever","id":127914705,"image":"https://g.foolcdn.com/editorial/images/778164/investor-thinks-while-looking-out-a-window.jpg","symbol":"LLY","publisher":"Yahoo","summary":"These players might even beat the market when the conditions are right.","url":"https://www.fool.com/investing/2024/05/26/got-500-3-pharma-stocks-to-buy-and-hold-forever/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1716727200,"headline":"SA Asks: Who will launch the next big weight-loss drug?","id":127915021,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3513478347"},{"category":"company","date":1716722137,"headline":"TCHP: Secretive And Unconvincing Growth ETF","id":127913479,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1478479389/image_1478479389.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"T. Rowe Price Blue Chip Growth ETF is an actively managed ETF with a portfolio of 74 companies. Read more to see my recommendation on TCHP fund.","url":"https://seekingalpha.com/article/4695725-tchp-secretive-and-unconvincing-growth-etf"},{"category":"company","date":1716720780,"headline":"Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?","id":127912311,"image":"https://g.foolcdn.com/editorial/images/778155/businessmen-and-doctors-working-on-touchpad-in-a-hospital.jpg","symbol":"LLY","publisher":"Yahoo","summary":"The gold rush for obesity medications just got a bit more intense.","url":"https://www.fool.com/investing/2024/05/26/amgens-catching-up-to-novo-nordisk-and-eli-lilly-s/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1716718500,"headline":"Parnassus Growth Equity Fund Q1 2024 Investment Commentary","id":127913192,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1503371245/image_1503371245.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Parnassus Growth Equity Fund returned 12.91%, better than the Russell 1000 Growthâs 11.41%. Click here to read the full report.","url":"https://seekingalpha.com/article/4695723-parnassus-growth-equity-fund-q1-2024-investment-commentary"},{"category":"company","date":1716673743,"headline":"Dow Jones Futures: What To Do As Market Rally Narrows But Keeps Rising; 7 Stocks Near Buy Points","id":127904691,"image":"https://media.zenfs.com/en/ibd.com/f10524724103d3259783022b8cfa1bdc","symbol":"LLY","publisher":"Yahoo","summary":"The market rally had a mixed week as breadth narrowed. Microsoft and Merck led stocks near buy points. Here's what to do.","url":"https://finance.yahoo.com/m/048fae1e-3098-3f44-a989-47f3e5b60f32/dow-jones-futures%3A-what-to-do.html"},{"category":"company","date":1716693338,"headline":"The Biggest Publicly Traded Biotech Company","id":127907361,"image":"https://s.yimg.com/ny/api/res/1.2/E4Rv08LePPx4eH.BwU0hYQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/f04aac56fc64efab59e0ea2140ecf98a","symbol":"LLY","publisher":"Yahoo","summary":"In this article, we will be discussing the biggest publicly traded biotech company that ranks at the top of our free list of the 20 Biggest Publicly Traded Biotech Companies. Biotechnology and Industry 2023: Market Growth, Transformations, and Technological Milestones The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate […]","url":"https://finance.yahoo.com/news/biggest-publicly-traded-biotech-company-031538946.html"},{"category":"company","date":1716634020,"headline":"3 High-Flying Stocks That Could Soar Even More","id":127900022,"image":"https://g.foolcdn.com/editorial/images/778486/stock-chart-rocket.jpg","symbol":"LLY","publisher":"Yahoo","summary":"The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.","url":"https://www.fool.com/investing/2024/05/25/3-high-flying-stocks-that-could-soar-even-more/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1716629100,"headline":"Viking, CRISPR, Intellia among potential M\u0026A targets: Wells Fargo","id":127900763,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3512408327"},{"category":"company","date":1716608160,"headline":"Elon Musk Says Ozempic 'Will Become Very Cheap' After New Comedy Special Paints It As Weight Loss Drug Only Wealthy People Can Afford","id":127900847,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3512148591"},{"category":"company","date":1716600420,"headline":"Eli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound","id":127897954,"image":"https://s.yimg.com/ny/api/res/1.2/UjFL6WUobTn9Mb4zqTaMzw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/3a560e2a21daa5b9331b7082176e15d9","symbol":"LLY","publisher":"Yahoo","summary":"The outlay to expand an Indiana production site, combined with a previous $3.7 billion commitment, is the largest manufacturing investment in company history.","url":"https://finance.yahoo.com/m/2027c3c2-d467-3230-9583-f71494393862/eli-lilly-to-spend-%245.3.html"},{"category":"company","date":1716586803,"headline":"Dow Jones Futures: Market Rally Narrows; Dow Giants Lead 7 Stocks Near Buy Points","id":127897113,"image":"https://media.zenfs.com/en/ibd.com/f10524724103d3259783022b8cfa1bdc","symbol":"LLY","publisher":"Yahoo","summary":"The market rally had a mixed week as breadth narrowed. Microsoft and Merck led stocks near buy points. Here's what to do.","url":"https://finance.yahoo.com/m/048fae1e-3098-3f44-a989-47f3e5b60f32/dow-jones-futures%3A-market.html"},{"category":"company","date":1716581039,"headline":"Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds","id":127897957,"image":"https://media.zenfs.com/en/Benzinga/5dab871cfd389ca5d19d9870ee695fd8","symbol":"LLY","publisher":"Yahoo","summary":"Friday, Eli Lilly And Company (NYSE:LLY) announced it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing its total investment from $3.7 billion to $9 billion. This expansion will enhance Lilly’s capacity to manufacture active pharmaceutical ingredients (API) for Zepbound (tirzepatide) injection and Mounjaro (tirzepatide) injection. Related: Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires M","url":"https://finance.yahoo.com/news/eli-lilly-makes-largest-manufacturing-200359716.html"},{"category":"company","date":1716579133,"headline":"Eli Lilly to Invest Another $5.3 Billion in Indiana Manufacturing Site","id":127897958,"image":"https://media.zenfs.com/en/mt_newswires_premium_news_706/6fcb0e4daa23894ba9c15e5da184e3ec","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly to Invest Another $5.3 Billion in Indiana Manufacturing Site","url":"https://finance.yahoo.com/news/eli-lilly-invest-another-5-193213672.html"},{"category":"company","date":1716568985,"headline":"Ether ETF approved, Live Nation antitrust suit: Morning Brief","id":127897648,"image":"https://s.yimg.com/ny/api/res/1.2/Vsv5sEjKrW.4LruSiMYg6A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/os/creatr-uploaded-images/2024-05/a9951230-19ec-11ef-bddf-7cf786c5ca93","symbol":"LLY","publisher":"Yahoo","summary":"After an eventful week compounded by Nvidia's (NVDA) fiscal first-quarter earnings, the major market averages (^DJI, ^IXIC, ^GSPC) are hoping to end the week on a high note and claw back some gains ahead of the Memorial Day Weekend. Morning Brief Hosts Seana Smith and Brad Smith walk investors through the top stories moving stocks in Friday's trading day, kicking off the session with Truist Co-Chief Investment Officer and Chief Market Strategist Keith Lerner who compares the market sway of Nvidia's latest earnings to that of inflation data or the Federal Reserve's monetary policy. The Securities and Exchange Commission (SEC) approved ether ETF offerings on Thursday, leading Bloomberg Intelligence ETF Research Analyst James Seyffart to believe ethereum-exposed (ETH-USD) products will have similar success to the spot bitcoin ETFs (BTC-USD) rolled out at the start of 2024, just not on the same scale. Other top trending stories include the latest in the Department of Justice's (DOJ) antitrust suit against concert promoter and ticket seller Live Nation (LYV) and Charter Communications' (CHTR) content distribution deal with Paramount Global (PARA). This post was written by Luke Carberry Mogan.","url":"https://finance.yahoo.com/video/ether-etf-approved-live-nation-164305541.html"},{"category":"company","date":1716567720,"headline":"NEW YORK MARKET CLOSE: Nasdaq closes a winning week on the front foot","id":127901109,"image":"","symbol":"LLY","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=b8mia5l8r1"},{"category":"company","date":1716562132,"headline":"Cytokinetics Decides To Go It Alone","id":127893401,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/824561510/image_824561510.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Cytokinetics, Incorporated stock plunges due to a botched capital raise, but their primary drug candidate shows blockbuster potential. Read more here.","url":"https://seekingalpha.com/article/4695559-cytokinetics-decides-to-go-it-alone"},{"category":"company","date":1716560883,"headline":"Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro","id":127897962,"image":"https://s.yimg.com/ny/api/res/1.2/Hld8_JWA827YS5RqispnaQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/ap_finance_articles_694/f442b955897b1f2e428e8429a22f41cc","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its popular weight-loss and diabetes treatments, Zepbound and Mounjaro.  The company broke ground for its Lebanon, Indiana, manufacturing plant last year and expects to start making products there near the end of 2026.  Lilly said it would add $5.3 billion to the $3.7 billion it had already slated for the site.","url":"https://finance.yahoo.com/news/eli-lilly-beefs-plan-expand-142803902.html"},{"category":"company","date":1716558540,"headline":"Eli Lilly invests additional USD5.3 billion in new Indiana plant","id":127893765,"image":"","symbol":"LLY","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=rapdrdevgk"},{"category":"company","date":1716558069,"headline":"Stocks open in the green, Dow hopeful to claw back losses","id":127891417,"image":"https://s.yimg.com/ny/api/res/1.2/4SlyyfBkOFpYFl3rys67Ng--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2024-05/c9fa7b70-19d1-11ef-b2af-06eb949e5ad9","symbol":"LLY","publisher":"Yahoo","summary":"Stocks (^DJI, ^IXIC, ^GSPC) edge higher at Friday's open, hoping to reclaim slight losses ahead of the long Memorial Day Weekend. Yahoo Finance Senior Markets Reporter Jared Blikre joins the Morning Brief to examine the market direction and this morning's across-the-board sector gains. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.","url":"https://finance.yahoo.com/video/stocks-open-green-dow-hopeful-134109541.html"},{"category":"company","date":1716557703,"headline":"Lilly invests further $5.3 billion in new Indiana site as obesity drug demand soars","id":127897965,"image":"https://media.zenfs.com/en/reuters.com/10f1fd766cd6297bb642d576bb07e1f1","symbol":"LLY","publisher":"Yahoo","summary":"(Reuters) -Eli Lilly said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, more than doubling its previous investment, as it scrambles to meet soaring demand for its weight-loss and diabetes drugs.  The new investment, which brings the total to $9 billion, will help boost production of the active pharmaceutical ingredients (API) for Lilly's powerful weight-loss drug Zepbound and diabetes treatment Mounjaro, the company said.  “Today’s announcement tops the largest manufacturing investment in our company’s history and, we believe, represents the single largest investment in synthetic medicine API manufacturing in U.S. history,” said Lilly CEO David Ricks.","url":"https://ca.finance.yahoo.com/news/lilly-invests-further-5-3-133503255.html"},{"category":"company","date":1716557400,"headline":"Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines","id":127897966,"image":"https://media.zenfs.com/en/prnewswire.com/3602e2fbed2389aeaf9c007ab20ed145","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly and Company (NYSE: LLY) announced today that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion. This expansion will enhance Lilly's capacity to manufacture active pharmaceutical ingredients (API) for Zepbound® (tirzepatide) injection and Mounjaro® (tirzepatide) injection so that more adults with chronic diseases like obesity and ty","url":"https://finance.yahoo.com/news/lilly-increases-manufacturing-investment-9-133000223.html"},{"category":"company","date":1716556740,"headline":"Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan \u0026 More","id":127897919,"image":"https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24","symbol":"LLY","publisher":"Yahoo","summary":"AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.","url":"https://finance.yahoo.com/news/pharma-stock-roundup-azns-2030-131900663.html"},{"category":"company","date":1716552900,"headline":"Lilly to pour $5B more into expanding Zepbound, Mounjaro production","id":127897969,"image":"https://www.biopharmadive.com/imgproxy/gBztnI7Xkwg_xvIRJT6Y-yWHQedQlkwZ7NyMB88KA0k/g:nowe:1762:1606/c:4237:2393/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTIwOTI0ODEzNDAuanBn.webp","symbol":"LLY","publisher":"Yahoo","summary":"The planned spending on new facilities in Lebanon, Indiana, brings its total commitment to the site to $9 billion, the largest single manufactuing investment in company history.","url":"https://www.biopharmadive.com/news/lilly-zepbound-manufacturing-invest-indiana-tirzepatide/717108/"},{"category":"company","date":1716548700,"headline":"What You Missed On Wall Street This Morning","id":127892038,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3511043979"},{"category":"company","date":1716548025,"headline":"Eli Lilly: invests $5.3 billion in its Indiana site","id":127891724,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"Eli Lilly has announced a major investment of $5.3 billion in its manufacturing site in Lebanon, Indiana, bringing the total investment to $9 billion. This operation is designed to boost production...","url":"https://finnhub.io/api/news?id=ee2b03188478b58ddb18880bb399fafb20fe39061b340084ac054ff8f20cda26"},{"category":"company","date":1716546960,"headline":"Lilly manufacturing expansion update 'significantly positive,' says BMO Capital","id":127893770,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3511011303"},{"category":"company","date":1716545880,"headline":"Eli Lilly (NYSE:LLY) Raises Manufacturing Investment to $9B","id":127893772,"image":"","symbol":"LLY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3510991696"},{"category":"company","date":1716544209,"headline":"Eli Lilly and : 2015 Global Health Programs Report","id":127891132,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"LILLY GLOBAL HEALTH PROGRAMS REPORT 2015 Finding New Solutions Through Partnership Table of...","url":"https://finnhub.io/"},{"category":"company","date":1716543960,"headline":"Eli Lilly to spend $5.3 billion to boost Zepbound, Mounjaro manufacturing","id":127893774,"image":"","symbol":"LLY","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3510955749"},{"category":"company","date":1716543780,"headline":"Zealand Pharma releases top-line phase 2 results on weight loss asset dapiglutide","id":127893185,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3510951234"},{"category":"company","date":1716542235,"headline":"Medifast: Significant Undervaluation Even As Struggles Persist","id":127890753,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1332206495/image_1332206495.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Medifast's financial performance is deteriorating rapidly due to the emergence of drug-weight loss competitors. Read why MED stock is a hold.","url":"https://seekingalpha.com/article/4695483-medifast-significant-undervaluation-even-as-struggles-persist"},{"category":"company","date":1716541980,"headline":"Eli Lilly to spend another $5.3B on production site for Mounjaro, Zepbound","id":127893779,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3510917811"},{"category":"company","date":1716539580,"headline":"Eli Lilly increases manufacturing investment to $9B for tirzepatide production","id":127893780,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3510875758"},{"category":"company","date":1716538860,"headline":"Eli Lilly to invest $5.3B more to boost weight-loss drug production, WSJ reports","id":127893781,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3510862656"},{"category":"company","date":1716538500,"headline":"Jim Cramer Says This Basic Materials Stock Is 'Too Dicey,' Shares His Take On Arista Networks","id":127893784,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3510857177"},{"category":"company","date":1716531180,"headline":"Novo weight loss therapy cuts mortality risk in kidney disease","id":127892149,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3510735477"},{"category":"company","date":1716530640,"headline":"Stocks to Buy: 7 Undeniable Dow Darlings to Pile Into Now","id":127893289,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3510727915"},{"category":"company","date":1716527220,"headline":"7 Stocks to Buy if the Market Ends Up Plunging","id":127892746,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3510678213"},{"category":"company","date":1716521280,"headline":"What You Missed On Wall Street On Thursday","id":127895447,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3511355833"},{"category":"company","date":1716520740,"headline":"Novo Nordisk once weekly insulin fails to get thumbs up from majority of FDA advisors","id":127904181,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3511345362"},{"category":"company","date":1716498000,"headline":"Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting","id":127881261,"image":"https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio® (abemaciclib; a CDK4/6 inhibitor), Retevmo® (selpercatinib; a rearranged during transfection [RET] inhibitor), olomorasib (an investigational KRAS G12C inhibitor) and imlunestrant (an investigational oral selective estrogen receptor degrader [SERD]) will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 31 – June 4 in Chicago.","url":"https://finance.yahoo.com/news/lilly-announces-details-presentations-2024-210000636.html"},{"category":"company","date":1716467940,"headline":"8 Health Care Stocks Whale Activity In Today's Session","id":127868529,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3509397908"},{"category":"company","date":1716467812,"headline":"Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus","id":127866214,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2064405960/image_2064405960.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Lantheus is actively expanding its pipeline by making strategic investments backed by a robust balance sheet. Read why I rate LNTH stock as a buy.","url":"https://seekingalpha.com/article/4695293-leading-the-growth-of-radiopharmaceuticals-mini-deep-dive-on-lantheus"},{"category":"company","date":1716465900,"headline":"3 Blue Chip Stocks That You Can Buy and Hold for Years","id":127865808,"image":"https://g.foolcdn.com/editorial/images/777830/a-family-reviewing-financial-results-with-an-advisor.jpg","symbol":"LLY","publisher":"Yahoo","summary":"You won't be taking on much risk by investing in these stalwarts.","url":"https://www.fool.com/investing/2024/05/23/3-blue-chip-stocks-that-you-can-buy-and-hold-for-y/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1716461100,"headline":"Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster","id":127866788,"image":"https://g.foolcdn.com/editorial/images/777989/physician-talking-to-patient.jpg","symbol":"LLY","publisher":"Yahoo","summary":"This winner can't stop winning.","url":"https://www.fool.com/investing/2024/05/23/surprise-eli-lilly-is-racing-toward-yet-another/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1716451440,"headline":"Analysts’ Top Healthcare Picks: Silk Road Medical (SILK), Eli Lilly \u0026 Co (LLY)","id":127866932,"image":"","symbol":"LLY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3509023188"},{"category":"company","date":1716444360,"headline":"South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next","id":127884491,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3509905705"},{"category":"company","date":1716443520,"headline":"Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.","id":127866935,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3508878958"},{"category":"company","date":1716438720,"headline":"Bonds Break Down And Send Everyone To Cash","id":127874984,"image":"","symbol":"LLY","publisher":"TalkMarkets","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3509750761"},{"category":"company","date":1716426540,"headline":"SA Asks: Is Eli Lilly or Novo Nordisk a better investment?","id":127884493,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3509440956"},{"category":"company","date":1716426360,"headline":"3 Biotech Stocks to Buy on the Dip: May 2024","id":127876490,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3509436741"},{"category":"company","date":1716412929,"headline":"Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?","id":127854903,"image":"https://s.yimg.com/ny/api/res/1.2/hKWg62RQ.kbRntamu6JeBw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/8e984c21a437e828274169c9f37cff34","symbol":"LLY","publisher":"Yahoo","summary":"In this article, we will be taking a look at is Eli Lilly and Company the largest publicly traded healthcare company? If you wish to learn about more companies, head straight to the Top 20 Largest Publicly Traded Healthcare Companies. Major Players Driving the U.S. Healthcare Industry’s Growth and Innovation The global healthcare industry is […]","url":"https://finance.yahoo.com/news/eli-lilly-company-largest-publicly-212209042.html"},{"category":"company","date":1716409532,"headline":"Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2024 Update","id":127854773,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Jeremy Grantham's 13F portfolio value surged to $27.52B as top holdings include Microsoft, Alphabet, Meta Platforms, UnitedHealth, and Apple. Explore more here.","url":"https://seekingalpha.com/article/4695130-tracking-jeremy-granthams-gmo-capital-portfolio-q1-2024-update"},{"category":"company","date":1716401880,"headline":"Hims \u0026 Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.","id":127849541,"image":"https://s.yimg.com/ny/api/res/1.2/HZmBvrOl1ExdcIwHWxXYog--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/f6dfc590c8c5bf13f31322023b2a5b0b","symbol":"LLY","publisher":"Yahoo","summary":"A plan by  Hims \u0026 Hers Health  to sell legal copies of  Novo Nordisk  weight loss drug Wegovy is drawing pushback from the industry, and bringing new attention to an area of concern for public-health officials.  Enormous demand has created shortages of Novo’s Wegovy, as well as a competing weight loss injection from Eli Lilly called Zepbound.  Both companies are spending billions of dollars to increase their manufacturing capacity, but the availability of the medicines is limited in the U.S., according to the Food and Drug Administration.","url":"https://finance.yahoo.com/m/75557e8e-623b-35b9-a8f0-40961ce90c21/hims-%26-hers-is-selling.html"},{"category":"company","date":1716400017,"headline":"Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns","id":127845062,"image":"https://media.zenfs.com/en/Benzinga/8f6ba12db185165d0d275b3897596dd9","symbol":"LLY","publisher":"Yahoo","summary":"Australia announced on Wednesday that it would ban compounded versions of weight-loss drugs like Novo Nordisk A/S’s (NYSE:NVO) Ozempic and Eli Lilly And Co’s (NYSE:LLY) Mounjaro, citing safety concerns. Recently, the Chinese regulatory authority approved Eli Lilly’s diabetes drug, tirzepatide. Health Minister Mark Butler emphasized that these unregulated copies have not undergone rigorous testing, leading to potential patient risks. Related: The Ozempic Diet: Nestle Launches $5 Pizza For Weight","url":"https://finance.yahoo.com/news/australia-bans-replica-versions-popular-174657340.html"},{"category":"company","date":1716398160,"headline":"Lilly (LLY) Hits Record High on Crohn's Disease Study Data","id":127847876,"image":"https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.","url":"https://finance.yahoo.com/news/lilly-lly-hits-record-high-171600055.html"},{"category":"company","date":1716384720,"headline":"Wall Street Lunch: Australia Bans Copycat Weight Loss Drugs","id":127842593,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1153740646/image_1153740646.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Australia to ban compounded versions of Novo Nordisk's semaglutide and Eli Lilly's tirzepatide due to safety concerns. Existing home sales dipped 1.89% in April to 4.14 million.","url":"https://seekingalpha.com/article/4695051-wall-street-lunch-australia-bans-copycat-weight-loss-drugs"},{"category":"company","date":1716381480,"headline":"Play These New ETFs to Tap Lucrative Weight Loss Drug Market","id":127841906,"image":"https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071","symbol":"LLY","publisher":"Yahoo","summary":"Global obesity rates have nearly tripled since 1975, per WHO and Goldman Sachs. The growing usage of GLP-1 drugs in weight management now makes the industry a thriving one.","url":"https://finance.yahoo.com/news/play-etfs-tap-lucrative-weight-123800304.html"},{"category":"company","date":1716379415,"headline":"Dow Jones Futures Fall As Target Tumbles; Nvidia Looms Over Stock Market","id":127837018,"image":"https://media.zenfs.com/en/ibd.com/d7d80fe376b5b68a90366f59253c34ff","symbol":"LLY","publisher":"Yahoo","summary":"The Nasdaq hit a new high Tuesday but Target tumbled early Wednesday. Will Nvidia earnings tonight meet lofty hopes?","url":"https://finance.yahoo.com/m/d8233539-4271-32c6-ad05-107f5762589f/dow-jones-futures-fall-as.html"},{"category":"company","date":1716376033,"headline":"Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo","id":127837771,"image":"https://media.zenfs.com/en/bloomberg_markets_842/4190fa593ee6540cb43f1df37c2b4578","symbol":"LLY","publisher":"Yahoo","summary":"(Bloomberg) -- Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics Inc. shares skyrocketing. But to reach the next level the biopharmaceutical developer likely needs a partner — or a buyer.Most Read from BloombergThese Flight Routes Suffer the World’s Worst TurbulenceOne Dead After Singapore Air Flight Hit By Severe Turbulence‘It Felt Like We Had Crashed’: Singapore Air Passenger Describes Turbulence TerrorBarclays Managers Warn Some Staff to Prepare fo","url":"https://finance.yahoo.com/news/weight-loss-upstart-viking-needs-110713553.html"},{"category":"company","date":1716373620,"headline":"FDA reviewers voice concerns over hypoglycemia with Novo Nordisk weekly insulin","id":127846690,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3507435561"},{"category":"company","date":1716372900,"headline":"The 500 Top Stocks to Buy in May, According to AI","id":127840545,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3507420166"},{"category":"company","date":1716368400,"headline":"Retire Rich: 3 Game-Changing Stocks to Own for the Next 10 Years","id":127845614,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3507326454"},{"category":"company","date":1716366123,"headline":"Eli Lilly’s mirikizumab shows promise in Phase III Crohn’s disease trial","id":127841909,"image":"https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2024/05/Eli-Lilly_shutterstock_2247310877.jpg","symbol":"LLY","publisher":"Yahoo","summary":"Mirikizumab demonstrated significant improvements in Crohn's disease patients.","url":"https://www.clinicaltrialsarena.com/news/eli-lilly-mirikizumab-trial/"},{"category":"company","date":1716358800,"headline":"Australia to ban copycat versions of weight loss drugs like Ozempic","id":127846693,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3507151422"},{"category":"company","date":1716326195,"headline":"Dow Jones Futures: Nasdaq Hits High, Eli Lilly Breaks Out, But Here Comes Nvidia","id":127823103,"image":"https://media.zenfs.com/en/ibd.com/d7d80fe376b5b68a90366f59253c34ff","symbol":"LLY","publisher":"Yahoo","summary":"Tuesday was a quiet session but the Nasdaq hit a record high while megacaps Eli Lilly and Microsoft flashed buy signals. Nvidia earnings loom large.","url":"https://finance.yahoo.com/m/d8233539-4271-32c6-ad05-107f5762589f/dow-jones-futures%3A-nasdaq.html"},{"category":"company","date":1716330018,"headline":"Australia to ban knock-offs of popular weight-loss drugs Ozempic, Mounjaro","id":127829271,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"Australia said on Wednesdayit will ban copies of drugs used for weight loss such as Ozempicand Mounjaro, arguing that so-called compounded versions are notrigorously tested and are potentially...","url":"https://finnhub.io/api/news?id=0489c1b5a9b75ed8d2c2e89175b0b6b037d67dec89403d2ac8447d4fe9a93d05"},{"category":"company","date":1716324143,"headline":"IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High","id":127827450,"image":"https://media.zenfs.com/en/ibd.com/f9b6fb256d6073617f867afba0139611","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly is Tuesday's IBD Stock Of The Day after shares surged into a buy zone, again, on promising test results for a Crohn's treatment.","url":"https://finance.yahoo.com/m/60d0b0f1-1daa-3b8c-a369-fa9c5c7fbcb4/ibd-stock-of-the-day-eli.html"},{"category":"company","date":1716302486,"headline":"If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today","id":127827452,"image":"https://g.foolcdn.com/editorial/images/777819/gettyimages-531714398.jpg","symbol":"LLY","publisher":"Yahoo","summary":"Have Eli Lilly's successes translated into stock performance?","url":"https://www.fool.com/investing/2024/05/21/if-youd-invested-10000-in-eli-lilly-stock-5-years/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1716298740,"headline":"Lilly partners with Aktis, deepening radiopharma investment","id":127827454,"image":"https://www.biopharmadive.com/imgproxy/Z-DSdjpHZohMo-YGs78X2fMyFA2Srmv56kOngckJrUY/g:ce/rs:fill:770:435:0/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTIwOTI0NzMyMTMuanBn.webp","symbol":"LLY","publisher":"Yahoo","summary":"The collaboration, which gives Lilly access to Aktis’ technology in return for $60 million, adds to a flurry of dealmaking in the radiopharma field.","url":"https://www.biopharmadive.com/news/aktis-eli-lilly-radiopharmaceuticals-cancer-deal/716700/"},{"category":"company","date":1716296280,"headline":"Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise, Tuesday, 5/21/2024","id":127821765,"image":"","symbol":"LLY","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=i7itrq8xsl"},{"category":"company","date":1716292800,"headline":"More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure","id":127827456,"image":"https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee","symbol":"LLY","publisher":"Yahoo","summary":"In Eli Lilly and Company's (NYSE: LLY) pivotal Phase 3 VIVID-1 study, patients with moderately to severely active Crohn's disease, with or without previous biologic failure, achieved statistically significant and clinically meaningful improvements across multiple clinical and endoscopic endpoints at one year with mirikizumab compared to placebo. Data from this study – the first Phase 3 treat-through data reported for an IL23p19 antibody – will be presented at Digestive Disease Week® (DDW), held","url":"https://finance.yahoo.com/news/more-one-half-patients-crohns-120000623.html"},{"category":"company","date":1716292260,"headline":"Eli Lilly’s stock on pace for record close as Crohn’s disease trial hits the mark","id":127824477,"image":"","symbol":"LLY","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505830145"},{"category":"company","date":1716288840,"headline":"Novo Nordisk unsure when it will meet obesity drug demand: report","id":127815802,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505755087"},{"category":"company","date":1716288506,"headline":"Eli Lilly: conclusive trial in Crohn's disease","id":127814085,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"Eli Lilly reports that in its phase 3 VIVID-1 trial, patients with moderately to severely active Crohn's disease showed significant improvements with mirikizumab versus placebo after one year. These...","url":"https://finnhub.io/api/news?id=cd78245048bba608e818668a34de74454a928aa6b130fb940dfedaf70e07d773"},{"category":"company","date":1716284820,"headline":"This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan","id":127845758,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3506695018"},{"category":"company","date":1716283920,"headline":"Roundhill Investment launches GLP-1 \u0026 Weight Loss ETF","id":127815803,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505650769"},{"category":"company","date":1716282540,"headline":"Eli Lilly pays $60M upfront for radiopharmaceutical pact with Aktis","id":127824481,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505621432"},{"category":"company","date":1716281700,"headline":"Early notable gainers among liquid option names on May 21st","id":127815344,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505603941"},{"category":"company","date":1716281451,"headline":"Eli Lilly Reports More than 50% Remission Rate in Crohn's Treatment Trial","id":127812901,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"By Dean Seal Eli Lilly reports that more than half of Crohn's disease patients achieved clinical remission after a year of treatment with mirikizumab in a recent trial. The pharmaceutical...","url":"https://finnhub.io/api/news?id=a8ff776c5f00a7bf0dc632f703e3f1b159b08661dc5357cc48923c0919f14788"},{"category":"company","date":1716281100,"headline":"7 Reliable Blue-Chip Stocks That Cannot Miss","id":127815804,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505590866"},{"category":"company","date":1716280860,"headline":"Eli Lilly Secures China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide","id":127815805,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505586887"},{"category":"company","date":1716280020,"headline":"Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds","id":127815806,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505569307"},{"category":"company","date":1716279300,"headline":"Eli Lilly inks radiopharma deal worth up to $1.1B with Aktis","id":127818647,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505555523"},{"category":"company","date":1716278760,"headline":"Tesla's Fall From Grace: Down 55% From Its Peak","id":127842656,"image":"","symbol":"LLY","publisher":"TalkMarkets","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3506541078"},{"category":"company","date":1716277816,"headline":"Eli Lilly's diabetes drug tirzepatide gets approval in China","id":127810104,"image":"https://media.zenfs.com/en/reuters-finance.com/b9b2fda094704986d4d98930bbc7a499","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, setting up intensifying competition with its Danish rival Novo Nordisk in the key Asian market.  Novo Nordisk's popular diabetes drug Ozempic won approval from China in 2021 and the company saw sales of the weekly injection in the greater China region that includes Hong Kong and Taiwan double to 4.8 billion Danish Krone ($698 million) last year.  Eli Lilly did not say when sales would begin in China or how many doses would be supplied.","url":"https://finance.yahoo.com/news/eli-lillys-diabetes-drug-tirzepatide-075016157.html"},{"category":"company","date":1716275220,"headline":"Eli Lilly \u0026 Co.: A Strong Buy on Robust Pipeline and Financial Health","id":127824488,"image":"","symbol":"LLY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505480393"},{"category":"company","date":1716275100,"headline":"Eli Lilly's mirikizumab shows efficacy in Crohn's disease","id":127824489,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505478630"},{"category":"company","date":1716272700,"headline":"3 S\u0026P 500 Stocks to Buy in May Before They Rocket Higher","id":127818784,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505437499"},{"category":"company","date":1716270240,"headline":"Eli Lilly’s tirzepatide cleared for diabetes treatment in China","id":127815807,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505400076"},{"category":"company","date":1716263280,"headline":"JPM lists stocks with the least price swings, most attractive option-sale candidates","id":127822235,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3506155804"},{"category":"company","date":1716262620,"headline":"EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic","id":127822193,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3506140182"},{"category":"company","date":1716261420,"headline":"What You Missed On Wall Street On Tuesday","id":127823437,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3506112402"},{"category":"company","date":1716259715,"headline":"Eli Lilly says its diabetes drug tirzepatide gets approval in China","id":127809452,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"Eli Lilly said onTuesday its tirzepatide drug has received approval from Chineseregulators for use to treat type 2 diabetes. Tirzepatide is the active ingredient in the U.S....","url":"https://finnhub.io/api/news?id=367e549e707fc044c071477191d9613cdb5214a5ed378fb2c47d1e27abff6430"},{"category":"company","date":1716255660,"headline":"3 Growth Stocks That Could Be Millionaire-Makers: May Edition","id":127818813,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505977713"},{"category":"company","date":1716255300,"headline":"Unveiling Eli Lilly and Co (LLY)'s Value: Is It Really Priced Right? A Comprehensive Guide","id":127824496,"image":"","symbol":"LLY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505970299"},{"category":"company","date":1716254820,"headline":"Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You","id":127824497,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505959554"},{"category":"company","date":1716253740,"headline":"Study finds 30% of Wegovy, Saxenda users quit within 4 weeks","id":127824498,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505934769"},{"category":"company","date":1716214258,"headline":"Magnificent Seven? Just Two Members Clear This Bar","id":127799059,"image":"https://media.zenfs.com/en/ibd.com/c3004ca564b83b3bd6311c01bf565fc7","symbol":"LLY","publisher":"Yahoo","summary":"Ultimately, earnings drive share prices. Only two Magnificent Seven stocks, and a third megacap, meet this triple-25% growth standard.","url":"https://finance.yahoo.com/m/59a2e761-7e6d-3306-8158-bad54247c5be/magnificent-seven%3F-just-two.html"},{"category":"company","date":1716214007,"headline":"FDLO: Low-Volatility ETF Beating Competitors","id":127799737,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1154062764/image_1154062764.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Fidelity Low Volatility Factor ETF invests in low-risk stocks, showing potential but with a short track record for long-term assessment. Click here for more on FDLO ETF.","url":"https://seekingalpha.com/article/4694585-fdlo-low-volatility-etf-beating-competitors"},{"category":"company","date":1716208320,"headline":"Here's How Much $100 Invested In Eli Lilly and Co 5 Years Ago Would Be Worth Today","id":127804960,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504238755"},{"category":"company","date":1716203520,"headline":"The Zacks Analyst Blog Highlights Microsoft,  Eli Lilly, Costco and Koss","id":127798171,"image":"https://media.zenfs.com/en/zacks.com/5d091b3e912681bbeabff8c176ea70a1","symbol":"LLY","publisher":"Yahoo","summary":"Microsoft, Eli Lilly, Costco and Koss are included in this Analyst Blog.","url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-microsoft-111200430.html"},{"category":"company","date":1716201720,"headline":"The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen","id":127796342,"image":"https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707","symbol":"LLY","publisher":"Yahoo","summary":"Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen are included in this Analyst Blog.","url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-stocks-104200359.html"},{"category":"company","date":1716200520,"headline":"Hims \u0026 Hers soars after announcing $199 weight loss shots","id":127800319,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504084144"},{"category":"company","date":1716199500,"headline":"Jefferies healthcare analysts hold an analyst/industry conference call","id":127798795,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504065087"},{"category":"company","date":1716196740,"headline":"Hims \u0026 Hers surges on cheap compounded versions of Novo Nordisk's semaglutide","id":127800320,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504013771"},{"category":"company","date":1716181380,"headline":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Johnson \u0026 Johnson (JNJ), Eli Lilly \u0026 Co (LLY) and Coherus Biosciences (CHRS)","id":127799285,"image":"","symbol":"LLY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3503778264"},{"category":"company","date":1716171420,"headline":"HIMS Stock Alert: Hims \u0026 Hers Shares Rocket on Weight Loss Injections","id":127804965,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504367041"},{"category":"company","date":1716120240,"headline":"VONG: Large-Cap Growth Breaks To New Highs, Bulls Defend Key Support","id":127789521,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3502700668"},{"category":"company","date":1716113700,"headline":"Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market?","id":127788856,"image":"https://g.foolcdn.com/editorial/images/777578/gettyimages-investor-works-at-computer.jpg","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly's biggest growth drivers today are its weight loss drugs.","url":"https://www.fool.com/investing/2024/05/19/is-amgen-a-threat-to-eli-lilly-in-this-market/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1716084420,"headline":"SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?","id":127790807,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3503224853"},{"category":"company","date":1716031133,"headline":"Roche Is Joining The Obesity Party But Questions Remain","id":127776256,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1767278670/image_1767278670.jpg?io=getty-c-w1536","symbol":"LLY","publisher":"SeekingAlpha","summary":"Roche's obesity candidate CT-388 shows promising weight loss results, with potential growth in their cardiometabolic pipeline. Read to learn more on the buy rating.","url":"https://seekingalpha.com/article/4694321-roche-is-joining-the-obesity-party-but-questions-remain"},{"category":"company","date":1715997240,"headline":"Novo Nordisk, J\u0026J lead R\u0026D rankings in big pharma: report","id":127778728,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3502273184"},{"category":"company","date":1715974140,"headline":"Top Research Reports for Microsoft, Eli Lilly \u0026 Costco","id":127769266,"image":"https://media.zenfs.com/en/zacks.com/44263f48df9be6f8f1d10cb79541249a","symbol":"LLY","publisher":"Yahoo","summary":"Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Eli Lilly and Company (LLY) and Costco Wholesale Corporation (COST), as well a micro-cap stock Koss Corporation (KOSS).","url":"https://finance.yahoo.com/news/top-research-reports-microsoft-eli-192900696.html"},{"category":"company","date":1715961420,"headline":"Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control","id":127760585,"image":"https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.","url":"https://finance.yahoo.com/news/eli-lillys-lly-efsitora-matches-155700847.html"},{"category":"company","date":1715960340,"headline":"Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates","id":127759077,"image":"https://media.zenfs.com/en/zacks.com/f91db6bb14dedc17d5edb20f29c41da3","symbol":"LLY","publisher":"Yahoo","summary":"Bayer (BAYRY) releases Q1 results. J\u0026J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.","url":"https://finance.yahoo.com/news/pharma-stock-roundup-bayrys-q1-153900251.html"},{"category":"company","date":1715954640,"headline":"4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly","id":127756681,"image":"https://media.zenfs.com/en/zacks.com/9f505d3082c5c32dd86790426e65a15d","symbol":"LLY","publisher":"Yahoo","summary":"Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this space.","url":"https://finance.yahoo.com/news/4-stocks-could-break-novo-140400901.html"},{"category":"company","date":1715950814,"headline":"Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know","id":127771071,"image":"https://s.yimg.com/ny/api/res/1.2/gZA5XMnsr1RRZw6lGNAcdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05NDA-/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0","symbol":"LLY","publisher":"Yahoo","summary":"Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.","url":"https://finance.yahoo.com/news/eli-lilly-company-lly-attracting-130014220.html"},{"category":"company","date":1715948640,"headline":"Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk","id":127754941,"image":"https://g.foolcdn.com/editorial/images/776990/doctor-meeting-a-salesperson.jpg","symbol":"LLY","publisher":"Yahoo","summary":"Could Amgen be the next stock to soar due to a GLP-1 drug?","url":"https://www.fool.com/investing/2024/05/17/meet-the-glp-1-drug-that-could-be-the-biggest-conc/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1715941869,"headline":"Eli Lilly’s efsitora alfa shows promise in Phase III T2D trials","id":127754672,"image":"https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2024/05/Eli-Lilly_shutterstock_2435857119.jpg","symbol":"LLY","publisher":"Yahoo","summary":"Once-weekly insulin efsitora alfa offered non-inferior A1C reduction in the QWINT-2 and QWINT-4 trials.","url":"https://www.clinicaltrialsarena.com/news/eli-lilly-t2d-trials/"},{"category":"company","date":1715938320,"headline":"Zacks Investment Ideas feature highlights: Apple, Eli Lilly and Crocs","id":127754673,"image":"https://media.zenfs.com/en/zacks.com/0a9b2d908daa277030d350cbcab5087f","symbol":"LLY","publisher":"Yahoo","summary":"Apple, Eli Lilly and Crocs have been highlighted in this Investment Ideas article.","url":"https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-093200886.html"},{"category":"company","date":1715926260,"headline":"Analysts Are Bullish on These Healthcare Stocks: Amgen (AMGN), Eli Lilly \u0026 Co (LLY)","id":127759415,"image":"","symbol":"LLY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500347802"},{"category":"company","date":1715911680,"headline":"EXCLUSIVE: GameStop, AMC Buzz 'May Prove To Be Short-Lived,' CEO Of Company Behind MEME ETF Tells Benzinga","id":127760544,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500897837"},{"category":"company","date":1715911320,"headline":"Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?","id":127761630,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500890038"},{"category":"company","date":1715910360,"headline":"Rally Rockets: 3 Stocks Benefitting From the Market’s Unstoppable Surge","id":127760546,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500869785"},{"category":"company","date":1715890140,"headline":"3 Stocks to Buy Following Positive Earnings Results","id":127754674,"image":"https://media.zenfs.com/en/zacks.com/6a88511086c20bde9695a01d9a366cd2","symbol":"LLY","publisher":"Yahoo","summary":"All three of these companies saw buyers step up post-earnings, reflecting the positivity of their results.","url":"https://finance.yahoo.com/news/3-stocks-buy-following-positive-200900946.html"},{"category":"company","date":1715868780,"headline":"3 Drug Stocks to Watch on Raised 2024 Earnings \u0026 Sales Guidance","id":127737450,"image":"https://media.zenfs.com/en/zacks.com/65d4d9838ddb692fbe578219ce60c69d","symbol":"LLY","publisher":"Yahoo","summary":"Here we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK), that have raised their earnings as well as sales guidance for 2024.","url":"https://finance.yahoo.com/news/3-drug-stocks-watch-raised-141300037.html"},{"category":"company","date":1715868480,"headline":"Roche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity","id":127736821,"image":"https://s.yimg.com/ny/api/res/1.2/Y1cYD1PCRuwdUpG94tTjjg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/2d4c1e5a8f896715f1230fd179df2bc9","symbol":"LLY","publisher":"Yahoo","summary":"The results, from a small trial of a drug called CT-388, hint that Roche could be a serious player in the weight-loss market in coming years.","url":"https://finance.yahoo.com/m/e4bf6074-ec9a-30b2-a1ae-01e66f081cca/roche%E2%80%99s-new-weight-loss-data.html"},{"category":"company","date":1715867040,"headline":"Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data","id":127737452,"image":"https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071","symbol":"LLY","publisher":"Yahoo","summary":"Data from the study shows that nearly half of the patients who received Roche's (RHHBY) subcutaneously-administered obesity drug lost more than 20% of their body weight after 24 weeks.","url":"https://finance.yahoo.com/news/roche-rhhby-posts-encouraging-phase-134400042.html"},{"category":"company","date":1715863440,"headline":"Roche data falls short of Viking weight loss drug, says Truist","id":127742613,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3499024034"},{"category":"company","date":1715863260,"headline":"Viking falls after Roche’s obesity drug data","id":127742614,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3499019295"},{"category":"company","date":1715861460,"headline":"Lilly’s once-weekly insulin matches daily shots in late-stage tests","id":127739680,"image":"https://www.biopharmadive.com/imgproxy/Z-DSdjpHZohMo-YGs78X2fMyFA2Srmv56kOngckJrUY/g:ce/rs:fill:770:435:0/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTIwOTI0NzMyMTMuanBn.webp","symbol":"LLY","publisher":"Yahoo","summary":"The results, which showed Lilly’s drug was as effective at controlling blood sugar as standard injections, come as Novo Nordisk seeks approval for a competing once-weekly insulin.","url":"https://www.biopharmadive.com/news/lilly-insulin-once-weekly-efsitora-alfa-diabetes/716331/"},{"category":"company","date":1715859092,"headline":"Dow Jones Futures Rise On Cisco, Walmart After Market Rally Hits Highs, Nvidia Breaks Out","id":127733601,"image":"https://media.zenfs.com/en/ibd.com/8c78ff5caff1abade9f14672809dad35","symbol":"LLY","publisher":"Yahoo","summary":"Futures rose on Cisco and Walmart. On Wednesday, the Dow, S\u0026P 500 and Nasdaq hit record highs, with Nvidia leading new buys.","url":"https://finance.yahoo.com/m/a15b3c54-37ee-33a2-a2c8-989e215e2985/dow-jones-futures-rise-on.html"},{"category":"company","date":1715851500,"headline":"Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial","id":127733486,"image":"https://s.yimg.com/ny/api/res/1.2/J2ehSIDlmgeDieCwWw0Khw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/c24235408934a40467907efacbed14ab","symbol":"LLY","publisher":"Yahoo","summary":"Roche Holding said a drug candidate achieved positive results for weight loss in an early-stage clinical trial in adults with obesity.","url":"https://finance.yahoo.com/m/0cae2e6c-3932-3116-a331-0820b1e2cf4a/roche-shares-climb-after.html"},{"category":"company","date":1715859660,"headline":"Analysts Offer Insights on Healthcare Companies: Eli Lilly \u0026 Co (LLY), Arvinas Holding Company (ARVN) and Progyny (PGNY)","id":127740028,"image":"","symbol":"LLY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498931409"},{"category":"company","date":1715858100,"headline":"These 2 No-Brainer Growth Stocks Are Breaking New Ground","id":127734976,"image":"https://g.foolcdn.com/editorial/images/777182/doctor-with-patient-talking.jpg","symbol":"LLY","publisher":"Yahoo","summary":"The future keeps getting brighter for these companies.","url":"https://www.fool.com/investing/2024/05/16/these-2-no-brainer-growth-stocks-are-breaking-new/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1715857421,"headline":"UPDATE 2-Lilly's weekly insulin as effective as daily doses in studies","id":127737456,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly said on Thursday its once-weekly insulin injection, efsitora, showed blood sugar reduction that was consistent with commonly used daily insulins across two studies in patients with type 2 diabetes.  Lilly and Novo Nordisk are both developing weekly injections for long-acting insulins that could reduce the treatment burden for patients with diabetes.  Novo's weekly injection, insulin icodec, has been recommended for approval in Europe and is under regulatory review in the United States.","url":"https://finance.yahoo.com/news/1-lillys-weekly-insulin-succeeds-110341705.html"},{"category":"company","date":1715856797,"headline":"Eli Lilly: research collaboration with Totus Medicines","id":127736791,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"Totus Medicines, billed as 'a company revolutionizing small-molecule drug discovery and development using covalent DNA-encoded libraries and AI tools', has announced a multi-target research...","url":"https://finnhub.io/api/news?id=7d4bb0ae12a857555d6cde11526c90bc844790fb9d8a7b25f5552be7054d9279"},{"category":"company","date":1715856300,"headline":"With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin","id":127737458,"image":"https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee","symbol":"LLY","publisher":"Yahoo","summary":"Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-2 and QWINT-4 phase 3 clinical trials evaluating once-weekly insulin efsitora alfa (efsitora) in adults with type 2 diabetes using insulin for the first time (insulin naïve) and those who require multiple daily insulin injections. In the treat-to-target clinical trials, efsitora showed non-inferior A1C reduction compared to the most commonly used daily basal insulins globally.","url":"https://finance.yahoo.com/news/once-week-dosing-insulin-efsitora-104500773.html"},{"category":"company","date":1715855152,"headline":"Eli Lilly: positive trials in type 2 diabetes","id":127736499,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"Eli Lilly announced today the first positive results of two Phase 3 clinical trials evaluating the once-weekly insulin efsitora alfa in adults with type 2 diabetes using insulin for the first time,...","url":"https://finnhub.io/api/news?id=b5ec1566315e7aadee1413676c378f6c6cc7d13f09a7a1b9c1b155973dab6b26"},{"category":"company","date":1715851980,"headline":"Novo Nordisk falls on reports of fire at construction site (update)","id":127738810,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498749358"},{"category":"company","date":1715851140,"headline":"Eli Lilly's Weekly Insulin Dose On Par With Commonly Used Daily Doses, Phase 3 Studies Show","id":127740031,"image":"","symbol":"LLY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498730933"},{"category":"company","date":1715848260,"headline":"Novo Nordisk falls on reports of fire at construction site","id":127738814,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498666545"},{"category":"company","date":1715847060,"headline":"Analysts Offer Insights on Healthcare Companies: Eli Lilly \u0026 Co (LLY), Celcuity (CELC) and 89bio (ETNB)","id":127740033,"image":"","symbol":"LLY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498639727"},{"category":"company","date":1715844944,"headline":"Eli Lilly Says Once-Weekly Insulin Meets Key Goal in Two Studies","id":127733621,"image":"","symbol":"LLY","publisher":"Finnhub","summary":"By Colin Kellaher Eli Lilly on Thursday said a pair of late-stage studies of its proposed once-weekly insulin efsitora alfa met their primary endpoints. The Indianapolis drugmaker said...","url":"https://finnhub.io/api/news?id=4b8a316abf68c451128ce84266ae552c845720bbce74502e98dc0700590ab77c"},{"category":"company","date":1715843640,"headline":"The Dividend Investor’s Playbook: 3 Stocks for Consistent Cash Flow in 2024","id":127738748,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498571079"},{"category":"company","date":1715843580,"headline":"Eli Lilly, Totus enter multi-target research collaboration","id":127740035,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498570786"},{"category":"company","date":1715840640,"headline":"Eli Lilly once-weekly insulin hits main goal in late-stage trials","id":127740038,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498519213"},{"category":"company","date":1715840460,"headline":"7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs","id":127738592,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498516236"},{"category":"company","date":1715838840,"headline":"Roche obesity therapy leads to ~19% weight loss in Phase 1 trial","id":127738594,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498490132"},{"category":"company","date":1715838840,"headline":"Eli Lilly announces QWINT-2, QWINT-4 meet primary endpoints","id":127740040,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498490393"},{"category":"company","date":1715836680,"headline":"Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade","id":127738595,"image":"","symbol":"LLY","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498457707"},{"category":"company","date":1715823900,"headline":"Viking falls after Roche’s obesity drug data; RayJay upgrades (update)","id":127745138,"image":"","symbol":"LLY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3499115576"},{"category":"company","date":1715822400,"headline":"Viking seen â����holding upâ���� against obesity competition as Roche presents data","id":127742619,"image":"","symbol":"LLY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3499079610"}]}